- Home
- EXEL vs DLB Comparison
EXEL vs DLB Comparison
Compare EXEL & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- DLB
- Stock Information
- Founded
- EXEL 1994
- DLB 1965
- Country
- EXEL United States
- DLB United States
- Employees
- EXEL N/A
- DLB N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- DLB Multi-Sector Companies
- Sector
- EXEL Health Care
- DLB Miscellaneous
- Exchange
- EXEL Nasdaq
- DLB Nasdaq
- Market Cap
- EXEL 9.8B
- DLB 7.9B
- IPO Year
- EXEL 2000
- DLB 2005
- Fundamental
- Price
- EXEL $43.04
- DLB $74.24
- Analyst Decision
- EXEL Buy
- DLB Strong Buy
- Analyst Count
- EXEL 18
- DLB 4
- Target Price
- EXEL $38.76
- DLB $101.75
- AVG Volume (30 Days)
- EXEL 3.9M
- DLB 387.6K
- Earning Date
- EXEL 05-13-2025
- DLB 05-01-2025
- Dividend Yield
- EXEL N/A
- DLB 1.78%
- EPS Growth
- EXEL 237.58
- DLB 36.08
- EPS
- EXEL 2.20
- DLB 2.64
- Revenue
- EXEL $2,298,922,000.00
- DLB $1,320,184,000.00
- Revenue This Year
- EXEL $10.39
- DLB $6.38
- Revenue Next Year
- EXEL $10.74
- DLB $4.65
- P/E Ratio
- EXEL $19.53
- DLB $28.12
- Revenue Growth
- EXEL 24.49
- DLB 4.03
- 52 Week Low
- EXEL $20.40
- DLB $66.35
- 52 Week High
- EXEL $48.85
- DLB $89.66
- Technical
- Relative Strength Index (RSI)
- EXEL 59.93
- DLB 42.61
- Support Level
- EXEL $42.21
- DLB $74.47
- Resistance Level
- EXEL $43.75
- DLB $75.63
- Average True Range (ATR)
- EXEL 1.60
- DLB 0.84
- MACD
- EXEL -0.09
- DLB -0.18
- Stochastic Oscillator
- EXEL 53.96
- DLB 9.04
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.